Bionovis — Biologic and Biosimilar Medicines
Provider 
Founded 2012
Sells To —
Pricing Model —
Ownership —

Portfolio of high-complexity biologic and biosimilar medicines produced and distributed by Bionovis across five medical specialties.
The portfolio spans hematology (eculizumab, pegfilgrastim), immunology (adalimumab, etanercept, golimumab, infliximab), neurology (interferon beta-1a), ophthalmology (aflibercept) and oncology (bevacizumab, nivolumab, pertuzumab, rituximab, trastuzumab), with medicines produced at the company's ANVISA-certified biopharmaceutical plant in Valinhos, Brazil.
The medicines are supplied to Brazil's public health system through productive development partnerships with originator and biosimilar developers including Samsung Bioepis, Janssen, Merck, Sandoz, Fresenius Kabi, Biocon and Dr. Reddy's, and to the private market through licensing and codevelopment agreements.
Biocon

Biocon — Biosimilars Portfolio
biocon.com
Sandoz

Biosimilars
sandoz.com
Cristália

Biotechnology APIs & Biosimilars
cristalia.com.br
Fresenius Kabi

Fresenius Kabi Brasil Biopharma
fresenius-kabi.com
Samsung Bioepis
Samsung Bioepis — Biosimilars Portfolio
samsungbioepis.com
Celltrion

Truxima
celltrion.com
| Attribute | Bionovis — Biologic and Biosimilar Medicines | Biocon — Biosimilars Portfolio | Biosimilars | Biotechnology APIs & Biosimilars | Fresenius Kabi Brasil Biopharma | Samsung Bioepis — Biosimilars Portfolio | Truxima | |
|---|---|---|---|---|---|---|---|---|
| Provider | ||||||||
| Founded | 2012 | 1978 | 1886 | 1972 | — | 2012 | — | |
| Sells To | — | Enterprise, Government | Healthcare Providers, Hospitals, Retail | Consumers, Hospitals | — | — | — | |
| Pricing Model | — | Recurring, Software, Transactional | B2B, Product Sales | Product Sales | — | — | — | |
| Ownership | — | Public | Public | Private | — | — | — |
Provider 
Founded 2012
Sells To —
Pricing Model —
Ownership —
Provider 
Founded 1978
Sells To Enterprise, Government
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider 
Founded 1886
Sells To Healthcare Providers, Hospitals, Retail
Pricing Model B2B, Product Sales
Ownership Public
Provider 
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —


Biologics development and contract manufacturing services from Brazil's first industrial-scale monoclonal antibody plant.


EMS's hospital unit supplying medicines and solutions to hospitals and institutional healthcare buyers, reinforced by a 2026 injectables acquisition.


Oncology portfolio of chemotherapies and targeted therapies described as Brazil's largest chemotherapy offering.


Hematology portfolio of chemotherapy agents and a rituximab biologic for blood cancers.
Biologics development and contract manufacturing services from Brazil's first industrial-scale monoclonal antibody plant.

EMS's hospital unit supplying medicines and solutions to hospitals and institutional healthcare buyers, reinforced by a 2026 injectables acquisition.

Oncology portfolio of chemotherapies and targeted therapies described as Brazil's largest chemotherapy offering.

Hematology portfolio of chemotherapy agents and a rituximab biologic for blood cancers.
